Report Detail
Global Intravitreal Injectable Supply, Demand and Key Producers, 2026-2032
- RnM4627330 |
- 22 January, 2026 |
- Global |
- 108 Pages |
- GIR |
- Pharma & Healthcare
The global Intravitreal Injectable market size is expected to reach $ 31120 million by 2032, rising at a market growth of 6.9% CAGR during the forecast period (2026-2032).
Intravitreal injectables are sterile pharmaceutical formulations administered directly into the vitreous humor of the eye using a fine needle. This route of administration allows for targeted delivery of medications—such as anti-VEGF agents, corticosteroids, or antibiotics—into the posterior segment of the eye, ensuring high local drug concentrations while minimizing systemic exposure. Intravitreal injections are commonly used to treat retinal diseases including age-related macular degeneration (AMD), diabetic macular edema (DME), retinal vein occlusion (RVO), and infectious endophthalmitis.
The global intravitreal injectable market has experienced steady growth in recent years, driven primarily by the rising prevalence of retinal disorders such as macular edema, age-related macular degeneration (AMD), and retinal vein occlusion (RVO). North America currently dominates the global market, holding a share of more than 50%, followed by Europe and Asia-Pacific, each with shares exceeding 40%.
In terms of drug types, anti-VEGF (vascular endothelial growth factor) therapies represent the largest and most significant market segment, contributing to over 85% of total market revenue. These agents are highly effective in inhibiting abnormal blood vessel growth in the retina, making them the standard of care for diseases like AMD and diabetic macular edema (DME). Other therapeutic classes such as corticosteroids and antibiotics play smaller roles, typically in more specialized or adjunctive treatment scenarios.
The largest clinical application of intravitreal injectables is for macular edema, which continues to see a rise in incidence linked to diabetes and aging populations worldwide. Macular degeneration and RVO are also major contributors to demand, reinforcing the importance of targeted ophthalmic treatments. The increase in awareness, earlier diagnosis, and improved accessibility to eye care services are further driving market expansion across both developed and emerging regions.
Looking ahead, the market is expected to grow steadily due to increasing disease burden and product innovation. Notably, new players such as Astellas Pharma have begun entering the market, signaling a shift toward broader competition and possibly next-generation therapies with extended efficacy and dosing intervals. Advances in drug delivery systems, longer-acting formulations, and biosimilars are expected to further shape the landscape and offer new growth opportunities.
This report studies the global Intravitreal Injectable demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Intravitreal Injectable, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intravitreal Injectable that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Intravitreal Injectable total market, 2021-2032, (USD Million)
Global Intravitreal Injectable total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Intravitreal Injectable total market, key domestic companies, and share, (USD Million)
Global Intravitreal Injectable revenue by player, revenue and market share 2021-2026, (USD Million)
Global Intravitreal Injectable total market by Drug, CAGR, 2021-2032, (USD Million)
Global Intravitreal Injectable total market by Disease, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Intravitreal Injectable market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Regeneron Pharmaceuticals, Bausch & Lomb, Novartis, AbbVie (Allergan), Alimera Sciences, Roche, Bristol-Myers Squibb, Bayer, Bausch + Lomb, EyePoint Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Intravitreal Injectable market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Drug, and by Disease. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Intravitreal Injectable Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Intravitreal Injectable Market, Segmentation by Drug:
Anti-VEGF Agents
Corticosteroids / Steroid Implants
Thrombolytic / Enzymatic Agents
Others
Global Intravitreal Injectable Market, Segmentation by Formulation Type:
Solution for Intravitreal Injection
Suspension for Intravitreal Injection
Others
Global Intravitreal Injectable Market, Segmentation by Duration of Action:
Short-acting (4–6 weeks)
Medium-acting (8–12 weeks)
Long-acting (> 6 months)
Global Intravitreal Injectable Market, Segmentation by Disease:
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
Companies Profiled:
Regeneron Pharmaceuticals
Bausch & Lomb
Novartis
AbbVie (Allergan)
Alimera Sciences
Roche
Bristol-Myers Squibb
Bayer
Bausch + Lomb
EyePoint Pharmaceuticals
Key Questions Answered
1. How big is the global Intravitreal Injectable market?
2. What is the demand of the global Intravitreal Injectable market?
3. What is the year over year growth of the global Intravitreal Injectable market?
4. What is the total value of the global Intravitreal Injectable market?
5. Who are the Major Players in the global Intravitreal Injectable market?
6. What are the growth factors driving the market demand?
1 Supply Summary
- 1.1 Intravitreal Injectable Introduction
- 1.2 World Intravitreal Injectable Market Size & Forecast (2021 & 2025 & 2032)
- 1.3 World Intravitreal Injectable Total Market by Region (by Headquarter Location)
- 1.3.1 World Intravitreal Injectable Market Size by Region (2021-2032), (by Headquarter Location)
- 1.3.2 United States Based Company Intravitreal Injectable Revenue (2021-2032)
- 1.3.3 China Based Company Intravitreal Injectable Revenue (2021-2032)
- 1.3.4 Europe Based Company Intravitreal Injectable Revenue (2021-2032)
- 1.3.5 Japan Based Company Intravitreal Injectable Revenue (2021-2032)
- 1.3.6 South Korea Based Company Intravitreal Injectable Revenue (2021-2032)
- 1.3.7 ASEAN Based Company Intravitreal Injectable Revenue (2021-2032)
- 1.3.8 India Based Company Intravitreal Injectable Revenue (2021-2032)
- 1.4 Market Drivers, Restraints and Trends
- 1.4.1 Intravitreal Injectable Market Drivers
- 1.4.2 Factors Affecting Demand
- 1.4.3 Major Market Trends
2 Demand Summary
- 2.1 World Intravitreal Injectable Consumption Value (2021-2032)
- 2.2 World Intravitreal Injectable Consumption Value by Region
- 2.2.1 World Intravitreal Injectable Consumption Value by Region (2021-2026)
- 2.2.2 World Intravitreal Injectable Consumption Value Forecast by Region (2027-2032)
- 2.3 United States Intravitreal Injectable Consumption Value (2021-2032)
- 2.4 China Intravitreal Injectable Consumption Value (2021-2032)
- 2.5 Europe Intravitreal Injectable Consumption Value (2021-2032)
- 2.6 Japan Intravitreal Injectable Consumption Value (2021-2032)
- 2.7 South Korea Intravitreal Injectable Consumption Value (2021-2032)
- 2.8 ASEAN Intravitreal Injectable Consumption Value (2021-2032)
- 2.9 India Intravitreal Injectable Consumption Value (2021-2032)
3 World Intravitreal Injectable Companies Competitive Analysis
- 3.1 World Intravitreal Injectable Revenue by Player (2021-2026)
- 3.2 Industry Rank and Concentration Rate (CR)
- 3.2.1 Global Intravitreal Injectable Industry Rank of Major Players
- 3.2.2 Global Concentration Ratios (CR4) for Intravitreal Injectable in 2025
- 3.2.3 Global Concentration Ratios (CR8) for Intravitreal Injectable in 2025
- 3.3 Intravitreal Injectable Company Evaluation Quadrant
- 3.4 Intravitreal Injectable Market: Overall Company Footprint Analysis
- 3.4.1 Intravitreal Injectable Market: Region Footprint
- 3.4.2 Intravitreal Injectable Market: Company Product Type Footprint
- 3.4.3 Intravitreal Injectable Market: Company Product Application Footprint
- 3.5 Competitive Environment
- 3.5.1 Historical Structure of the Industry
- 3.5.2 Barriers of Market Entry
- 3.5.3 Factors of Competition
- 3.6 Mergers & Acquisitions Activity
4 United States VS China VS Rest of World (by Headquarter Location)
- 4.1 United States VS China: Intravitreal Injectable Revenue Comparison (by Headquarter Location)
- 4.1.1 United States VS China: Intravitreal Injectable Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
- 4.1.2 United States VS China: Intravitreal Injectable Revenue Market Share Comparison (2021 & 2025 & 2032)
- 4.2 United States Based Companies VS China Based Companies: Intravitreal Injectable Consumption Value Comparison
- 4.2.1 United States VS China: Intravitreal Injectable Consumption Value Comparison (2021 & 2025 & 2032)
- 4.2.2 United States VS China: Intravitreal Injectable Consumption Value Market Share Comparison (2021 & 2025 & 2032)
- 4.3 United States Based Intravitreal Injectable Companies and Market Share, 2021-2026
- 4.3.1 United States Based Intravitreal Injectable Companies, Headquarters (States, Country)
- 4.3.2 United States Based Companies Intravitreal Injectable Revenue, (2021-2026)
- 4.4 China Based Companies Intravitreal Injectable Revenue and Market Share, 2021-2026
- 4.4.1 China Based Intravitreal Injectable Companies, Company Headquarters (Province, Country)
- 4.4.2 China Based Companies Intravitreal Injectable Revenue, (2021-2026)
- 4.5 Rest of World Based Intravitreal Injectable Companies and Market Share, 2021-2026
- 4.5.1 Rest of World Based Intravitreal Injectable Companies, Headquarters (Province, Country)
- 4.5.2 Rest of World Based Companies Intravitreal Injectable Revenue (2021-2026)
5 Market Analysis by Drug
- 5.1 World Intravitreal Injectable Market Size Overview by Drug: 2021 VS 2025 VS 2032
- 5.2 Segment Introduction by Drug
- 5.2.1 Anti-VEGF
- 5.2.2 Steroids
- 5.2.3 Others
- 5.3 Market Segment by Drug
- 5.3.1 World Intravitreal Injectable Market Size by Drug (2021-2026)
- 5.3.2 World Intravitreal Injectable Market Size by Drug (2027-2032)
- 5.3.3 World Intravitreal Injectable Market Size Market Share by Drug (2027-2032)
6 Market Analysis by Disease
- 6.1 World Intravitreal Injectable Market Size Overview by Disease: 2021 VS 2025 VS 2032
- 6.2 Segment Introduction by Disease
- 6.2.1 Macular Degeneration
- 6.2.2 Macular Edema
- 6.2.3 Uveitis
- 6.2.4 Retinal Vein Occlusion
- 6.2.5 Others
- 6.3 Market Segment by Disease
- 6.3.1 World Intravitreal Injectable Market Size by Disease (2021-2026)
- 6.3.2 World Intravitreal Injectable Market Size by Disease (2027-2032)
- 6.3.3 World Intravitreal Injectable Market Size Market Share by Disease (2021-2032)
7 Company Profiles
- 7.1 Regeneron Pharmaceuticals (Eylea)
- 7.1.1 Regeneron Pharmaceuticals (Eylea) Details
- 7.1.2 Regeneron Pharmaceuticals (Eylea) Major Business
- 7.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product and Services
- 7.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Revenue, Gross Margin and Market Share (2021-2026)
- 7.1.5 Regeneron Pharmaceuticals (Eylea) Recent Developments/Updates
- 7.1.6 Regeneron Pharmaceuticals (Eylea) Competitive Strengths & Weaknesses
- 7.2 Allergan
- 7.2.1 Allergan Details
- 7.2.2 Allergan Major Business
- 7.2.3 Allergan Intravitreal Injectable Product and Services
- 7.2.4 Allergan Intravitreal Injectable Revenue, Gross Margin and Market Share (2021-2026)
- 7.2.5 Allergan Recent Developments/Updates
- 7.2.6 Allergan Competitive Strengths & Weaknesses
- 7.3 EyePoint Pharmaceuticals
- 7.3.1 EyePoint Pharmaceuticals Details
- 7.3.2 EyePoint Pharmaceuticals Major Business
- 7.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Product and Services
- 7.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Revenue, Gross Margin and Market Share (2021-2026)
- 7.3.5 EyePoint Pharmaceuticals Recent Developments/Updates
- 7.3.6 EyePoint Pharmaceuticals Competitive Strengths & Weaknesses
- 7.4 Genentech
- 7.4.1 Genentech Details
- 7.4.2 Genentech Major Business
- 7.4.3 Genentech Intravitreal Injectable Product and Services
- 7.4.4 Genentech Intravitreal Injectable Revenue, Gross Margin and Market Share (2021-2026)
- 7.4.5 Genentech Recent Developments/Updates
- 7.4.6 Genentech Competitive Strengths & Weaknesses
- 7.5 Kanghong Pharmaceutical
- 7.5.1 Kanghong Pharmaceutical Details
- 7.5.2 Kanghong Pharmaceutical Major Business
- 7.5.3 Kanghong Pharmaceutical Intravitreal Injectable Product and Services
- 7.5.4 Kanghong Pharmaceutical Intravitreal Injectable Revenue, Gross Margin and Market Share (2021-2026)
- 7.5.5 Kanghong Pharmaceutical Recent Developments/Updates
- 7.5.6 Kanghong Pharmaceutical Competitive Strengths & Weaknesses
- 7.6 Astellas Pharma
- 7.6.1 Astellas Pharma Details
- 7.6.2 Astellas Pharma Major Business
- 7.6.3 Astellas Pharma Intravitreal Injectable Product and Services
- 7.6.4 Astellas Pharma Intravitreal Injectable Revenue, Gross Margin and Market Share (2021-2026)
- 7.6.5 Astellas Pharma Recent Developments/Updates
- 7.6.6 Astellas Pharma Competitive Strengths & Weaknesses
- 7.7 Clearside Biomedical
- 7.7.1 Clearside Biomedical Details
- 7.7.2 Clearside Biomedical Major Business
- 7.7.3 Clearside Biomedical Intravitreal Injectable Product and Services
- 7.7.4 Clearside Biomedical Intravitreal Injectable Revenue, Gross Margin and Market Share (2021-2026)
- 7.7.5 Clearside Biomedical Recent Developments/Updates
- 7.7.6 Clearside Biomedical Competitive Strengths & Weaknesses
- 7.8 Bayer
- 7.8.1 Bayer Details
- 7.8.2 Bayer Major Business
- 7.8.3 Bayer Intravitreal Injectable Product and Services
- 7.8.4 Bayer Intravitreal Injectable Revenue, Gross Margin and Market Share (2021-2026)
- 7.8.5 Bayer Recent Developments/Updates
- 7.8.6 Bayer Competitive Strengths & Weaknesses
8 Industry Chain Analysis
- 8.1 Intravitreal Injectable Industry Chain
- 8.2 Intravitreal Injectable Upstream Analysis
- 8.3 Intravitreal Injectable Midstream Analysis
- 8.4 Intravitreal Injectable Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
- 10.1 Methodology
- 10.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Intravitreal Injectable. Industry analysis & Market Report on Intravitreal Injectable is a syndicated market report, published as Global Intravitreal Injectable Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Intravitreal Injectable market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
